{"id":"W2760849249","doi":"10.1186/s12967-017-1309-2","title":"Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016","year":2017,"lang":"en","type":"article","venue":"Journal of Translational Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"National Center for Advancing Translational Sciences; Society for Immunotherapy of Cancer","keywords":"Atezolizumab; Durvalumab; Nivolumab; Medicine; Immunotherapy; Pembrolizumab; Avelumab; Oncology; Immune checkpoint; Ipilimumab; Targeted therapy; Melanoma; Internal medicine; Cancer; Cancer research; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001780071,0.0002240509,0.0006009804,0.0001607034,0.0002774603,0.00004492876,0.0004086459,0.0001107847,0.0009135818],"category_scores_gemma":[0.0003084361,0.0001287086,0.0003018726,0.0001272277,0.0005082428,0.0002924502,0.00001073578,0.0005213877,0.000003334577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001311647,"about_ca_system_score_gemma":0.0004251989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002066433,"about_ca_topic_score_gemma":0.0002066519,"domain_scores_codex":[0.9975057,0.00009220998,0.001106697,0.0002170098,0.0008442997,0.0002340487],"domain_scores_gemma":[0.9974639,0.0004425173,0.00109177,0.0005681645,0.0003532424,0.00008040085],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03267948,0.0009371648,0.434369,0.00005807943,0.004156936,0.001678905,0.03232079,0.00004831891,0.2929168,0.0004075798,0.02780702,0.1726199],"study_design_scores_gemma":[0.01264914,0.0003697362,0.9372555,0.001495348,0.00009528058,0.001060523,0.0008876354,0.00003444658,0.0004808375,0.001170069,0.04435302,0.0001484823],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7277254,0.07219461,0.0009589099,0.1893371,0.00143089,0.0004978564,0.00002315578,0.00001773839,0.007814318],"genre_scores_gemma":[0.9892944,0.005192809,0.0009306074,0.001605923,0.002390696,0.000005117239,0.00001320947,0.00003656698,0.0005306444],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5028864,"threshold_uncertainty_score":0.9999997,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04251446897132561,"score_gpt":0.344089545070107,"score_spread":0.3015750760987814,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}